Psoriatic Arthritis (PsA) Treatment Market Shares, Strategies and Forecast Worldwide, 2017 to 2027
Future Market Insights has announced the addition of the “Psoriatic Arthritis (PsA) Treatment Market: Global Industry Analysis and Opportunity Assessment 2017-2027" report to their offering.
Future Market Insights has announced the addition of the “Psoriatic Arthritis (PsA) Treatment Market: Global Industry Analysis and Opportunity Assessment 2017-2027" report to their offering.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Psoriatic</strong> <strong>Arthritis</strong> (<strong>PsA</strong>) <strong>Treatment</strong> <strong>Market</strong><br />
April <strong>2017</strong><br />
Report Id : REP-GB-2718<br />
Status : Ongoing<br />
Category : Healthcare, Pharmaceuticals & Medical Devices<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved
About<br />
Future <strong>Market</strong> Insights<br />
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, cus<strong>to</strong>m<br />
research reports, <strong>and</strong> consulting services. We deliver a complete packaged solution, which<br />
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth<br />
insights, aerial view of the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC,<br />
ASEAN, <strong>and</strong> BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,<br />
Technology, Healthcare, <strong>and</strong> Retail.<br />
We have a global presence with delivery centers across India specializing in providing global<br />
research reports <strong>and</strong> country research reports. FMI is headquartered out of London, U.K., with a<br />
state-of-the-art delivery center located in Pune, India. We combine our knowledge <strong>and</strong> learning<br />
from every corner of the world <strong>to</strong> distill it <strong>to</strong> one thing – the perfect solution for our client.<br />
Research Capabilities<br />
Sec<strong>to</strong>r Coverage<br />
<br />
<br />
<br />
<br />
Cus<strong>to</strong>mized Research<br />
Syndicated Research<br />
Investment Research<br />
Social Media Research<br />
<br />
<br />
<br />
<br />
Au<strong>to</strong>motive <strong>and</strong> Transportation<br />
Electronics, Semiconduc<strong>to</strong>r, <strong>and</strong> ICT<br />
Retail <strong>and</strong> Consumer Products<br />
Industrial Au<strong>to</strong>mation <strong>and</strong> Equipment<br />
<br />
<br />
<br />
<br />
Chemicals & Materials<br />
Food <strong>and</strong> Beverages<br />
Services <strong>and</strong> Utilities<br />
Energy, Mining, Oil, <strong>and</strong> Gas<br />
Cus<strong>to</strong>mized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
2
Research Methodology (1/2)<br />
Systematic Research Approach<br />
<strong>Market</strong> profiling<br />
Formulating discussion guide<br />
Developing list of respondents<br />
Data collection<br />
Data validation<br />
4<br />
5<br />
3<br />
1<br />
2<br />
In-depth secondary research is used <strong>to</strong><br />
ascertain overall market size, <strong>to</strong>p<br />
industry players, <strong>to</strong>p products, industry<br />
associations, etc.<br />
PMR formulates a detailed discussion<br />
guide <strong>to</strong> conduct expert <strong>and</strong> industry<br />
interviews<br />
PMR develops a list of industry players<br />
(manufacturers), distribu<strong>to</strong>rs, retailers<br />
<strong>and</strong> industry experts<br />
PMR conducts interviews with industry<br />
experts, industry players, distribu<strong>to</strong>rs<br />
<strong>and</strong> retailers<br />
Data is validated by triangulation<br />
method, wherein secondary, primary<br />
<strong>and</strong> PMR analysis contribute <strong>to</strong> the final<br />
data<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Data<br />
Collection<br />
Data Filter<br />
& Analysis<br />
Identifying key opinion leaders<br />
Questionnaire design<br />
In-depth interviews<br />
Coverage across value chain<br />
<strong>Market</strong> participants<br />
Key strengths<br />
Product portfolio<br />
Mapping as per value chain<br />
Key focus segments<br />
A<br />
Primary<br />
Research<br />
C<br />
Company<br />
Analysis<br />
Research &<br />
Intelligence<br />
SOLUTION<br />
Actionable<br />
Insights<br />
B<br />
Desk<br />
Research<br />
<br />
<br />
<br />
<br />
<br />
<br />
Business<br />
Solution<br />
Key industry experts<br />
Channel study<br />
Developments<br />
<strong>Market</strong> dynamics<br />
Products<br />
Conclusions<br />
Data analysis<br />
6<br />
Data is scrutinized using MS-Excel <strong>to</strong><br />
obtain qualitative <strong>and</strong> quantitative<br />
insights about the industry<br />
Primary Research #<br />
Secondary Research #<br />
Paid Publications#<br />
Insights<br />
7<br />
PMR delivers industry insights <strong>and</strong><br />
information in the required format<br />
(PDF)<br />
<br />
<br />
<br />
<br />
Linkedin<br />
Zoominfo<br />
Salesforce<br />
Avention<br />
<br />
<br />
<br />
<br />
Company websites<br />
Company annual<br />
reports<br />
White papers<br />
Financial reports<br />
<br />
<br />
<br />
<br />
Factiva<br />
GBI<br />
Genios<br />
Meltwater<br />
# includes sources of databases<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
3
<strong>Psoriatic</strong> <strong>Arthritis</strong> (<strong>PsA</strong>) <strong>Treatment</strong> <strong>Market</strong><br />
<strong>Psoriatic</strong> arthritis (<strong>PsA</strong>) is an inflamma<strong>to</strong>ry condition that causes inflammation of joints. <strong>Psoriatic</strong> arthritis<br />
affects both the skin <strong>and</strong> the musculoskeletal system. Musculoskeletal symp<strong>to</strong>ms include joint pain,<br />
swelling, tenderness, morning stiffness, reduction in joint movement; skin symp<strong>to</strong>ms include reddening<br />
<strong>and</strong> thickness of the skin, separation on the nail bed; other symp<strong>to</strong>ms include general fatigue,<br />
inflammation of the membrane lining the eyelid <strong>Psoriatic</strong> arthritis mainly affect those who are affected<br />
with skin disease known as psoriasis. Out of 10 people with psoriasis, only one or two will develop<br />
arthritis. Psoriasis is characterized by scaly red <strong>and</strong> white skin patches that may affect any joint in the<br />
body such as elbows, knees, scalp, including the spine <strong>and</strong> others.<br />
<strong>Psoriatic</strong> arthritis is caused due <strong>to</strong> genetic <strong>and</strong> environmental fac<strong>to</strong>rs. It often, often between the ages of<br />
30 <strong>and</strong> 50 years, but it can also develop in children called psoriatic type juvenile idiopathic arthritis. It is<br />
more common in Caucasians people than African Americans or Asian. According <strong>to</strong> disease control <strong>and</strong><br />
prevention, about five <strong>to</strong> seven percent of the population suffer from psoriasis, out of these 10-20%<br />
people will develop psoriatic arthritis. Diagnosis of the psoriatic arthritis is done by rheuma<strong>to</strong>logists, by<br />
looking at the swollen <strong>and</strong> painful joints, skin <strong>and</strong> nail change by various diagnostic procedures like X-<br />
rays, MRI, ultrasound, CT scans <strong>and</strong> others<br />
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-2718<br />
<strong>Treatment</strong> for psoriatic arthritis depends on its severity. Various over-the-counter (OTC) drugs <strong>and</strong><br />
prescribed drugs are available for treatment. Drugs prescribed for psoriatic arthritis includes immunesuppressing<br />
drugs, Non-steroidal drugs, <strong>and</strong> various biologics.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 4
<strong>Psoriatic</strong> <strong>Arthritis</strong> (<strong>PsA</strong>) <strong>Treatment</strong> <strong>Market</strong><br />
Biologics works by s<strong>to</strong>pping the inflamma<strong>to</strong>ry process, mainly tumor necrosis fac<strong>to</strong>r (TNF) <strong>and</strong> interleukin<br />
(IL) inhibi<strong>to</strong>rs are used <strong>to</strong> treat psoriatic arthritis. Different ways for the treatment include Short-term<br />
oral therapy, Low-dose, ongoing oral therapy or Injection administered directly in<strong>to</strong> the joint. Change on<br />
lifestyle such as physical exercise, limiting alcohol intake, weight management etc. may also help in the<br />
treatment process. Psoriasis is a severe disease affecting about 100 million individuals globally, according<br />
<strong>to</strong> world health organization prevalence of psoriasis in countries ranges 0.09% <strong>to</strong> 11.43%. Patient with<br />
psoriasis is at higher risk of developing other clinical conditions such as CVD <strong>and</strong> other noncommunicable<br />
diseases.<br />
The global psoriatic arthritis (<strong>PsA</strong>) treatment market is segmented on basis of mechanism of action,<br />
disease condition, distribution channel <strong>and</strong> geography<br />
Segment by Mechanism of Action<br />
TNF inhibi<strong>to</strong>rs<br />
PDE4 inhibi<strong>to</strong>rs<br />
Interleukin blockers<br />
Others<br />
Visit for TOC@ http://www.futuremarketinsights.com/<strong>to</strong>c/rep-gb-2718<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 5
<strong>Psoriatic</strong> <strong>Arthritis</strong> (<strong>PsA</strong>) <strong>Treatment</strong> <strong>Market</strong><br />
Segment by Disease Condition<br />
Mild psoriatic arthritis<br />
Moderate psoriatic arthritis<br />
Severe psoriatic arthritis<br />
Segment by Distribution Channel<br />
Hospital Pharmacy<br />
Drug S<strong>to</strong>res<br />
Retail Pharmacy<br />
E-commerce<br />
Global psoriatic arthritis (<strong>PsA</strong>) treatment market is segmented by mechanism of action, disease condition<br />
<strong>and</strong> distribution channel. Based on the product type, global psoriatic arthritis (<strong>PsA</strong>) treatment market is<br />
segmented TNF inhibi<strong>to</strong>rs, PDE4 inhibi<strong>to</strong>rs, <strong>and</strong> Interleukin blockers.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 6
<strong>Psoriatic</strong> <strong>Arthritis</strong> (<strong>PsA</strong>) <strong>Treatment</strong> <strong>Market</strong><br />
TNF-α inhibi<strong>to</strong>rs are said <strong>to</strong> revolutionize the market. IL-17 inhibi<strong>to</strong>rs are the latest wave, as companies<br />
are developing new biologics based on this inhibi<strong>to</strong>r. On the basis of disease condition, the global<br />
psoriatic arthritis (<strong>PsA</strong>) treatment market is segmented in<strong>to</strong> mild psoriatic arthritis, moderate psoriatic<br />
arthritis <strong>and</strong> severe psoriatic arthritis. On the basis of distribution channel, the global psoriatic arthritis<br />
(<strong>PsA</strong>) treatment market is segmented in<strong>to</strong> hospital pharmacy, drug s<strong>to</strong>res, retail pharmacy <strong>and</strong> e-<br />
commerce. Rise in incidence of psoriatic arthritis, increased awareness of healthcare professional <strong>and</strong><br />
new product launch is said <strong>to</strong> drive the global psoriatic arthritis (<strong>PsA</strong>) treatment market during the<br />
forecast period. Whereas inadequate access <strong>to</strong> health care, cost <strong>and</strong> availability of essential medicines<br />
<strong>and</strong> lack of st<strong>and</strong>ardized <strong>to</strong>ols for diagnosis <strong>and</strong> treatment will hamper the growth of global psoriatic<br />
arthritis (<strong>PsA</strong>) treatment market.<br />
Full Report Analysis@ http://www.futuremarketinsights.com/reports/psoriatic-arthritis-psa-treatmentmarket<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 7
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new <strong>to</strong>pics email us on:<br />
sales@futuremarketinsights.com<br />
For media queries, contact the press office at<br />
press@futuremarketinsights.com<br />
For other queries contact:<br />
Harish Tiwari<br />
(General Manager & Global Head Business Development)<br />
Future <strong>Market</strong> Insights: 3rd Floor,<br />
207 Regent Street, London W1B 3HH<br />
T: +44 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
Thank You<br />
Future <strong>Market</strong> Insights Global & Consulting Private Limited (FMI)<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
8
Change language